from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0364/-

LFCtreatmentdescriptionclass of inhibitor

0.318

Amikacinug/mL Amikacintranslation

1.415

Cap5-10ug/mL Capreomycintranslation

1.056

Rox10-50 ug/mL Roxithromycintranslation

0.820

SM2-5 ug/mL Streptomycintranslation

0.613

Tet5-10 ug/mL Tetracyclinetranslation

0.294

Rif0.2-5ug/mL Rifampicintranscription

-0.516

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.320

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.978

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.139

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.772

Clofazimine10-13 ug/mL Clofaziminerespiration

0.063

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.434

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.658

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.151

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.003

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.213

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.062

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.093

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.499

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.097

KCN5-20 ug/mL Potassium cyaniderespiration

-0.798

NaN30.2-2 mM Sodium aziderespiration

0.551

Nigericin50 uM Nigericinrespiration

-1.043

TRC10-150 ug/mL Triclosanrespiration

-0.655

TRZ10-25 ug/mL Thioridazinerespiration

-1.350

Valinomycin0.5-10 uM Valinomycinrespiration

0.689

ZnSO42 mM ZnSO4respiration

-0.036

menadione6-10 ug/mL Menadionerespiration

-0.114

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.392

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.218

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.574

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.172

NRP_1Non-replicating persistence stage 1dosRassociated

0.586

Amp0.2mg/mL AmpicillincellWall

0.371

Cephalexin20-100 ug/mL CephalexincellWall

1.028

Cerulenin0.32-5 ug/mL CerulenincellWall

0.249

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.295

EMB10-20 ug/mL EthambutolcellWall

0.784

Eta12-40 ug/mL EthionamidecellWall

1.228

INH0.2-0.4 ug/mL IsoniazidcellWall

0.488

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.392

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.029

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.632

BZA0.12 mg/mL BenzamidearomaticAmides

-0.299

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.169

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.670

H2O24 mM hydrogen peroxideDNAdamaging

0.264

Levo10 ug/mL LevofloxacinDNAdamaging

0.921

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.900

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.686

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.142

UVUV-irradiationDNAdamaging

-0.162

ARP41-4 ug/mL Antitubercular compound ARP4?

0.457

Antimycin12.5-50 ug/mL Antimycin A?

0.266

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.381

PA_110-50 ug/mL Antitubercular compound PA-1?

0.022

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.056

PA8240.2-2 ug/mL PA-824?

-1.502

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.259

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.365

Verapamil50 uM Verapamil?

-0.278

mercaptoethanol2 mM 2-Mercaptoethanol?

0.107

methoxatin10-20 ug/mL Methoxatin?